What are the recommendations for using Heptasan and clobazam (an anxiolytic medication) for appetite stimulation in pediatric patients with poor appetite?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 6, 2026 • View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Heptasan and Clobazam for Appetite Stimulation in Children

Direct Answer

Neither Heptasan nor clobazam have established evidence or guideline support for use as appetite stimulants in pediatric patients with poor appetite. These medications are not recommended for this indication based on available clinical evidence.

Evidence Analysis

Clobazam's Established Role

  • Clobazam is a 1,5-benzodiazepine approved as adjunctive therapy for epilepsy (particularly Lennox-Gastaut syndrome) and anxiety disorders, not for appetite stimulation 1, 2
  • Its mechanism involves allosteric activation of GABA(A) receptors, providing anxiolytic and anticonvulsant effects without direct appetite-enhancing properties 2
  • Common adverse effects include sedation, drowsiness, ataxia, vomiting, and behavioral changes—none of which would support appetite enhancement 3

Heptasan Identification Issue

  • No evidence was identified regarding "Heptasan" as an appetite stimulant in the provided literature
  • This medication name does not appear in standard pediatric appetite stimulation protocols or guidelines

Evidence-Based Alternatives for Pediatric Appetite Stimulation

Cyproheptadine represents the most studied option:

  • In a retrospective study of 127 pediatric patients with poor growth, 96% of parents reported positive changes in mealtime behaviors when cyproheptadine was combined with multidisciplinary feeding interventions 4
  • Significant improvement in weight-for-age z-scores occurred after starting cyproheptadine, independent of age or underlying medical conditions 4
  • This represents the strongest available evidence for pharmacologic appetite stimulation in children with feeding difficulties

Prokinetic agents show limited evidence:

  • Trimebutine combined with behavioral feeding recommendations improved appetite scores and nutritional parameters in children with delayed gastric emptying 5
  • However, this approach targets a specific subpopulation (those with documented gastric motility disorders) rather than general poor appetite 5

Clinical Pitfalls

  • Avoid off-label benzodiazepine use: Clobazam's sedative and behavioral side effects would likely worsen feeding difficulties rather than improve them 3
  • Identify underlying causes: Poor appetite may result from gastric motility disorders, behavioral factors, or underlying medical conditions requiring targeted intervention 5
  • Prioritize non-pharmacologic approaches: Multidisciplinary feeding programs with behavioral interventions form the foundation of treatment before considering appetite stimulants 4

References

1
Research

Clobazam: pharmacological and therapeutic profile.

British journal of clinical pharmacology, 1979

5
Research

Prokinetic agents in childen with poor appetite.

Acta gastro-enterologica Belgica, 2005

Related Questions

What is the novel mechanism of action of clobazam (a benzodiazepine)?
Should cyproheptadine be taken before or after food?
Can I give cyproheptadine (peripherally acting antihistamine) empirically for 2 weeks to increase appetite in a 10-year-old patient with a normal abdominal (abd) examination and thyroid examination, and then check Thyroid Function Tests (TFT) and Ultrasound (USG) afterwards?
Is it safe to give a 6-year-old patient with a history of seizure disorders, currently on clobazam and Depakote (valproate), Zofran (ondansetron) 4mg for nausea or vomiting?
Are there any indications for clobazam (a benzodiazepine) for pain management?
What is the recurrence rate of malignant phyllodes tumors (Phyllodes tumor) post-operation without radiotherapy (radiation therapy)?
What is the recommended dosage of fluconazole (an antifungal medication) for a patient with a surgical site infection due to candidiasis, considering factors such as severity of infection, impaired renal function, age, weight, and medical history?
Is baclofen (a muscle relaxant) a suitable treatment option for an older adult patient with trigeminal neuralgia, possibly with a history of hypertension or diabetes, who has not responded to first-line therapies?
What is a suitable appetite stimulant for pediatric patients with poor appetite?
Can a phyllodes tumor (a type of breast tumor) be passed on to children?
What is the best course of action for a patient with Systemic Lupus Erythematosus (SLE) and normal Complement 3 (C3) levels, presenting with neurological symptoms, such as frequent headaches and vomiting, suggestive of increased intracranial pressure?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Ask Question